Mitchell Austin Rudy Purchases 9,000 Shares of Bonk (NASDAQ:BNKK) Stock

Bonk, Inc. (NASDAQ:BNKK) Director Mitchell Austin Rudy bought 9,000 shares of the business’s stock in a transaction on Monday, July 13th. The stock was bought at an average cost of $1.21 per share, with a total value of $10,890.00. Following the transaction, the director owned 95,000 shares in the company, valued at $114,950. This trade represents a 10.47% increase in their position. The purchase was disclosed in a legal filing with the SEC, which is available at this link.

Mitchell Austin Rudy also recently made the following trade(s):

• On Friday, July 10th, Mitchell Austin Rudy bought 1,000 shares of Bonk stock. The shares were bought at an average price of $1.21 per share, with a total value of $1,210.00.
• On Thursday, July 2nd, Mitchell Austin Rudy purchased 11,659 shares of Bonk stock. The shares were purchased at an average cost of $1.47 per share, for a total transaction of $17,138.73.
• On Monday, June 22nd, Mitchell Austin Rudy bought 7,500 shares of Bonk stock. The stock was purchased at an average cost of $1.56 per share, for a total transaction of $11,700.00.
• On Tuesday, June 16th, Mitchell Austin Rudy acquired 2,500 shares of Bonk stock. The stock was acquired at an average cost of $1.32 per share, for a total transaction of $3,300.00.
• On Wednesday, June 10th, Mitchell Austin Rudy bought 12,000 shares of Bonk stock. The shares were acquired at an average price of $1.37 per share, with a total value of $16,440.00.

Bonk Trading Down 0.8%

Shares of BNKK stock opened at $1.30 on Thursday. Bonk, Inc. has a 12 month low of $1.14 and a 12 month high of $46.90. The stock has a market cap of $10.40 million, a P/E ratio of -0.28 and a beta of 1.89. The company has a 50 day simple moving average of $1.67 and a two-hundred day simple moving average of $2.68.

Bonk (NASDAQ:BNKK) last issued its quarterly earnings results on Wednesday, May 13th. The company reported ($0.23) earnings per share for the quarter. Bonk had a negative return on equity of 148.62% and a negative net margin of 838.37%.The business had revenue of $0.79 million for the quarter.

Hedge Funds Weigh In On Bonk

A number of hedge funds have recently made changes to their positions in BNKK. State Street Corp purchased a new stake in shares of Bonk during the fourth quarter worth about $33,000. Steward Partners Investment Advisory LLC purchased a new position in Bonk in the 4th quarter worth approximately $37,000. Jane Street Group LLC purchased a new position in Bonk in the 4th quarter worth approximately $96,000. Finally, Geode Capital Management LLC bought a new position in Bonk in the 4th quarter worth approximately $128,000. Institutional investors own 12.55% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities research analysts recently issued reports on the stock. Weiss Ratings lowered shares of Bonk from a “sell (d-)” rating to a “sell (e+)” rating in a report on Wednesday, April 29th. Wall Street Zen upgraded shares of Bonk from a “sell” rating to a “hold” rating in a research report on Saturday, July 4th. One equities research analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, Bonk presently has an average rating of “Sell”.

Bonk Company Profile

Safety Shot, Inc, a wellness and functional beverage company, engages in the research and development of over-the-counter products and intellectual property. Its products pipeline includes Photocil to address psoriasis and vitiligo; JW-700 to treat hair loss; JW-500 for women’s sexual wellness; NoStingz, a jellyfish sting prevention sunscreen; and JW-110 for the treatment of atopic dermatitis/eczema. The company primarily sell its products through third-party physical retail stores and partners. The company was formerly known as Jupiter Wellness, Inc and changed its name to Safety Shot, Inc in September 2023.